The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
H pylori antibiotic resistance: prevalence, importance, and advances in testing
Open accessAbstract
he discovery that Helicobacter pylori infection is the main cause of most gastroduodenal diseases has been a major breakthrough in gastroenterology.It has dramatically changed the management of these diseases which are now considered as infectious diseases and are treated with antibiotics.Triple therapy, including two antibiotics, amoxicillin and clarithromycin, and a proton pump inhibitor given for a week has been recommended as the treatment of choice at several consensus conferences.[1][2][3][4][5][6] However, this treatment may fail for several reasons, as reported elsewhere.7 In fact, the main reason for failure was found to be H pylori resistance to one of the antibiotics used (that is, clarithromycin).Other treatments have also been proposed, including metronidazole, a drug for which resistance is also a problem although to a lesser extent, as well as tetracycline, fluoroquinolones, and rifamycins for which resistance has become an emerging issue.8 9 Our aim was to review the prevalence of H pylori resistance to these various antibiotics, their clinical importance, and methods of testing, especially in light of the resistance mechanism which allows application of molecular methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
Self-citationMalfertheiner, P., Mégraud, F., OʼMorain, C., Bell, D., Porro, B. G., Deltenre, M., Forman, D., Gasbarrini, G., Jaup, B., Misiewicz, J. J., et al. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199701000-00002 · Cited by 980
Self-citationThe LightCycler TM : A Microvolume Multisample Fluorimeter with Rapid Temperature Control
Wittwer, C. T., Ririe, K. M., Andrew, R. V., David, D. A., Gundry, R. A., & Balis, U. J. (1997) · BioTechniques · doi:10.2144/97221pf02 · Cited by 893
Variation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
Versalovic, J., Shortridge, D., Kibler, K., Griffy, M. V., Beyer, J., Flamm, R. K., Tanaka, S. K., Graham, D. Y., & Go, M. F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.477 · Cited by 501
Helicobacter Pylori: Physiology and Genetics
Mobley, H. L. T., Mendz, G. L., & Hazell, S. L. (2001) · Cited by 441
Lind, T., Mégraud, F., Unge, P., Bayerdörffer, E., O'Morain, C., Spiller, R., van Zanten, S. V., Bardhan, K. D., Hellblom, M., Wrangstadh, M., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70119-8 · Cited by 434
Self-citationLAM, S., & TALLEY, N. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00537.x · Cited by 424
Houben, Beek, D. V. D., Hensen, Craen, A. J. M. D., Rauws, & Tytgat (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00555.x · Cited by 333
Mégraud, F., Lehn, N., Lind, T., Bayerdörffer, E., O’Morain, C., Spiller, R., Unge, P., van Zanten, S. V., Wrangstadh, M., & Burman, C. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2747 · Cited by 265
Laine, L. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06010-0 · Cited by 240
Broutet, N. J. N., Tchamgoué, S., Pereira, E., Lamouliatte, H., Salamon, R., & Mégraud, F. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01396.x · Cited by 221
Self-citationReview article: the treatment of refractory Helicobacter pylori infection
Mégraud, F., & Lamouliatte, H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01592.x · Cited by 211
Self-citationMcMahon, B. J., Hennessy, T. W., Bensler, J. M., Bruden, D. L., Parkinson, A. J., Morris, J. M., Reasonover, A. L., Hurlburt, D. A., Bruce, M. G., Sacco, F., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00008 · Cited by 198
The Maastricht Consensus Report. Dual publication.
Loffeld, R. J. (1998) · PubMed · Cited by 189
Rifampin and Rifabutin Resistance Mechanism in Helicobacter pylori
Heep, M., Beck, D., Bayerdörffer, E., & Lehn, N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1497 · Cited by 180
Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline
Trieber, C. A., & Taylor, D. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2131-2140.2002 · Cited by 174
Osato, M. S., Reddy, R., Reddy, S. G., Penland, R. L., Malaty, H. M., & Graham, D. Y. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1217 · Cited by 172
Kim, J. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.459 · Cited by 165
Peura, D. A. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)80003-0 · Cited by 163
Katelaris, P. H., Forbes, G. M., Talley, N. J., & Crotty, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.37051 · Cited by 160
Hultén, K. G., Gibreel, A., Sköld, O., & Engstrand, L. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2550 · Cited by 157
Trebesius, K., Panthel, K., Strobel, S., Vogt, K., Faller, G., Kirchner, T., Kist, M., Heesemann, J., & Haas, R. (2000) · Gut · doi:10.1136/gut.46.5.608 · Cited by 153
Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1075-1077.2000 · Cited by 153
Tankovic, J., Lascols, C., Sculo, Q., Petit, J., & Soussy, C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3942-3944.2003 · Cited by 141
Cabrita, J. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.1029 · Cited by 137
16S rRNA Mutation-Mediated Tetracycline Resistance in Helicobacter pylori
Gerrits, M. M., de Zoete, M. R., Arents, N. L. A., Kuipers, E. J., & Kusters, J. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2996-3000.2002 · Cited by 137
Chisholm, S., Owen, R. J., Teare, E. L., & Saverymuttu, S. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1217-1220.2001 · Cited by 133
Alfertheiner, P. M., & Roup, S. T. G. (2002) · Cited by 132
Debets-Ossenkopp, Y. J., Herscheid, A. J., Pot, R. G. J., Kuipers, E. J., Kusters, J. G., & Vandenbroucke‐Grauls, C. M. J. E. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.511 · Cited by 128
Marais, A., Monteiro, L., Occhialini, A., Pina, M., Lamouliatte, H., & Mégraud, F. (1999) · Gut · doi:10.1136/gut.44.4.463 · Cited by 120
Self-citationHigh-Level β-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori
Kwon, D. H., Dore, M. P., Kim, J. J., Kato, M., Lee, M., Wu, J., & Graham, D. Y. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2169-2178.2003 · Cited by 107
Gerrits, M. M., Schuijffel, D. F., van Zwet, A. A., Kuipers, E. J., Vandenbroucke‐Grauls, C. M. J. E., & Kusters, J. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2229-2233.2002 · Cited by 103
Kato, M., Yamaoka, Y., Kim, J. J., Reddy, R., Asaka, M., Kashima, K., Osato, M. S., El-Zaatari, F. A., Graham, D. Y., & Kwon, D. H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2214-2216.2000 · Cited by 103
Dailidiene, D., Bertoli, M. T., Miciuleviciene, J., Mukhopadhyay, A. K., Dailide, G., Pascasio, M. A., Kupcinskas, L., & Berg, D. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3940-3946.2002 · Cited by 101
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori
Okamoto, T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf140 · Cited by 100
Peitz, U., Sulliga, M., Wolle, K., Leodolter, A., von Arnim, U., Kahl, S., Stolte, M., Börsch, G., Labenz, J., & Malfertheiner, P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01173.x · Cited by 97
Toracchio, S., & Marzio, L. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00265-2 · Cited by 95
Molecular testing for antibiotic resistance in Helicobacter pylori
Owen, R. J. (2002) · Gut · doi:10.1136/gut.50.3.285 · Cited by 95
Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin
Wu, H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.1.121 · Cited by 89
CanadianHelicobacter pyloriConsensus Conference Update: Infections in Adults
Hunt, R. H., Fallone, C. A., Thomson, A., & Canadian Helicobacter Study Group (1999) · Canadian Journal of Gastroenterology · doi:10.1155/1999/180751 · Cited by 89
Lascols, C., Lamarque, D., Costa, J., Copie‐Bergman, C., Glaunec, J.-M. L., Deforges, L., Soussy, C., Petit, J., Delchier, J., & Tankovic, J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4573-4577.2003 · Cited by 88
Maeda, S., Yoshida, H., Matsunaga, H., Ogura, K., Kawamata, O., Shiratori, Y., & Omata, M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.210-214.2000 · Cited by 83
Marais, A., Bilardi, C., Cantet, F., Mendz, G. L., & Mégraud, F. (2003) · Research in Microbiology · doi:10.1016/s0923-2508(03)00030-5 · Cited by 82
Self-citationJ. Nilsson, V. S. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750024461 · Cited by 77
Novel Method for Rapid Determination of Clarithromycin Sensitivity in Helicobacter pylori
Gibson, J. R., Saunders, N. A., Burke, B., & Owen, R. J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3746-3748.1999 · Cited by 77
Characterization of an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori
DeLoney‐Marino, C. R., & Schiller, N. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3368-3373.2000 · Cited by 75
Effects of 16S rRNA Gene Mutations on Tetracycline Resistance in Helicobacter pylori
Gerrits, M. M., Berning, M., Van Vliet, A. H. M., Kuipers, E. J., & Kusters, J. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2984-2986.2003 · Cited by 75
Paul, R., Postius, S., Melchers, K., & Schäfer, K. P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.962-965.2001 · Cited by 74
Miki, I., Aoyama, N., Sakai, T., Shirasaka, D., Wambura, C. M., Maekawa, S., Kuroda, K., Tamura, T., Kita, T., Sakaeda, T., et al. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200301000-00006 · Cited by 72
Kalach, N., Bergeret, M., Benhamou, P., Dupont, C. M., & Raymond, J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.394-397.2001 · Cited by 71
Clarithromycin Resistance and Eradication of Helicobacter pylori in Children
Kalach, N., Benhamou, P., Campeotto, F., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2134-2135.2001 · Cited by 64
Samra, Z., Shmuely, H., Niv, Y., Dinari, G., Passaro, D. J., Geler, A., Gal, E., Fishman, M., Bachor, J., & Yahav, J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf041 · Cited by 61
Debets-Ossenkopp, Y. J., Brinkman, A. B., Kuipers, E. J., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2749 · Cited by 56
Feydt-Schmidt, A., Rüssmann, H., Lehn, N., Fischer, A., Antoni, I., Störk, D., & Koletzko, S. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01382.x · Cited by 53
Bontems, P., Devaster, J., Corvaglia, L., Dezsőfi, A., den Borre, C. V., Goutier, S., Butzler, J., & Cadranel, S. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200111000-00006 · Cited by 50
Tankovic, J., Lamarque, D., Lascols, C., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00971.x · Cited by 46
Dammann, H., Fölsch, U. R., Hahn, E. G., Kleist, D. H. V., Klör, H., Kirchner, T., Strobel, S., & Kist, M. (2000) · Helicobacter · doi:10.1046/j.1523-5378.2000.00006.x · Cited by 43
Yang, Y., Yang, J., Jeng, Y., Chang, M., & Ni, Y. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200107000-00005 · Cited by 37
Antibiotic Susceptibility and Resistance
Mégraud, F., Hazell, S. L., & Glupczynski, Y. (2014) · ASM Press eBooks · doi:10.1128/9781555818005.ch42 · Cited by 24
Self-citationBurgos, E. C., Forné, M., Quintana, S., Lite, J., & Garau, J. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72778-x · Cited by 22
Antibiotic resistance in Helicobacter pylori
Guslandi, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77256-1 · Cited by 10
Cited by
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.007 · Cited by 1,270
Helicobacter pylori treatment in the era of increasing antibiotic resistance
Graham, D. Y., & Fischbach, L. (2010) · Gut · doi:10.1136/gut.2009.192757 · Cited by 1,028
Megraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
Metadata
- Authors
- Mégraud, F.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-08-11
- Volume
- 53
- Issue
- 9
- Pages
- 1374-1384
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2136210283
- Cited by
- 955
- References
- 63
- FWCI
- 29.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.